Evrys Bio

Headquarters

Doylestown, PA

Evrys Bio is a privately held biotech focused on developing first-in-class antiviral therapies that target host cell sirtuin proteins to treat a broad spectrum of viruses and prevent drug resistance. The company is developing allosteric small molecule SIRT2 modulators and has a clinic-ready asset (EV-100) poised for proof-of-concept data.

• IN
  Intervir LLCIntervir LLC is a pharmaceutical manufacturing company focused on discovering novel antiviral therapeutics.PHILADELPHIA, PA
• PH
  PhylloPharmaPhylloPharma is developing oral delivery systems for protein drugs through encapsulation in plant cells, addressing challenges of traditional sterile injections and cold storage. The company's platform targets viral disease treatments including SARS-CoV-2, Influenza, CMV, EBV, Hepatitis C, and Herpes viruses.PHILADELPHIA, PA
• Hsiri TherapeuticsHsiri Therapeutics is a private biopharmaceutical company dedicated to discovering and developing novel antibiotics to treat multi-drug resistant infections, with a focus on gram-negative bacteria and mycobacterial diseases. The company's research efforts are focused on infections due to mycobacteria, usual bacterial pathogens resistant to current treatments, and drug-resistant fungal pathogens.MEDIA, PA
• Krystal Biotech, IncKrystal Biotech, Inc. is a commercial-stage biotechnology company developing and commercializing genetic medicines for patients with rare diseases using a proprietary redosable HSV-1 vector platform. The company operates integrated manufacturing facilities and has an approved gene therapy product, VYJUVEK, for dystrophic epidermolysis bullosa.325412PITTSBURGH, PA